Bank of America’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84
| Closed | -$127 | – | 8174 |
|
|
2023
Q2 | $127 | Hold |
84
| – | – | ﹤0.01% | 7409 |
|
|
2023
Q1 | $147 | Sell |
84
-8
| -9% | -$13 | ﹤0.01% | 7451 |
|
|
2022
Q4 | $174 | Buy |
92
+40
| +77% | +$88 | ﹤0.01% | 7571 |
|
|
2022
Q3 | $0 | Sell |
52
-20
| -28% | -$84 | ﹤0.01% | 8605 |
|
|
2022
Q2 | $0 | Hold |
72
| – | – | ﹤0.01% | 8829 |
|
|
2022
Q1 | $1K | Sell |
72
-4
| -5% | -$49 | ﹤0.01% | 8189 |
|
|
2021
Q4 | $1K | Sell |
76
-46
| -38% | -$1.09K | ﹤0.01% | 8146 |
|
|
2021
Q3 | $4K | Sell |
122
-46
| -27% | -$1.3K | ﹤0.01% | 7806 |
|
|
2021
Q2 | $6K | Sell |
168
-4,051
| -96% | -$151K | ﹤0.01% | 7412 |
|
|
2021
Q1 | $175K | Buy |
4,219
+4,020
| +2,020% | +$250K | ﹤0.01% | 6120 |
|
|
2020
Q4 | $12K | Sell |
199
-239
| -55% | -$25.9K | ﹤0.01% | 6695 |
|
|
2020
Q3 | $59K | Buy |
438
+218
| +99% | +$36.4K | ﹤0.01% | 5956 |
|
|
2020
Q2 | $37K | Sell |
220
-107
| -33% | -$17.8K | ﹤0.01% | 6099 |
|
|
2020
Q1 | $47K | Sell |
327
-447
| -58% | -$137K | ﹤0.01% | 5897 |
|
|
2019
Q4 | $255K | Buy |
774
+24
| +3% | +$11K | ﹤0.01% | 5470 |
|
|
2019
Q3 | $375K | Buy |
750
+111
| +17% | +$62.6K | ﹤0.01% | 5275 |
|
|
2019
Q2 | $388K | Sell |
639
-25
| -4% | -$15.3K | ﹤0.01% | 5232 |
|
|
2019
Q1 | $406K | Buy |
664
+206
| +45% | +$112K | ﹤0.01% | 5142 |
|
|
2018
Q4 | $168K | Sell |
458
-178
| -28% | -$95.7K | ﹤0.01% | 5635 |
|
|
2018
Q3 | $430K | Buy |
636
+414
| +186% | +$293K | ﹤0.01% | 5064 |
|
|
2018
Q2 | $193K | Buy |
222
+217
| +4,340% | +$249K | ﹤0.01% | 5436 |
|
|
2018
Q1 | $6K | Sell |
5
-31
| -86% | -$45.8K | ﹤0.01% | 6748 |
|
|
2017
Q4 | $53K | Buy |
36
+30
| +500% | +$47.4K | ﹤0.01% | 6049 |
|
|
2017
Q3 | $13K | Hold |
6
| – | – | ﹤0.01% | 6461 |
|
|
2017
Q2 | $16K | Buy |
+6
| New | +$15.5K | ﹤0.01% | 6298 |
|
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 7517 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6901 |
|
Bank of America's NBRV Position: Q3 2023 in Review
Bank of America sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2023, closing a stake of 84 shares — an estimated $127 sold.
Bank of America first reported a position in NBRV in Q2 2017 and held it in 25 quarters. The position peaked at $430K in Q3 2018. 0 funds tracked by Wall St. Rank hold NBRV as of Q3 2023.
- Bank of America reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2023 after selling out during the quarter.
- Bank of America sold 84 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2023, an estimated $127.
- Bank of America first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2017 and held it in 25 quarters.
- Bank of America's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $430K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2023.
Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.